Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Juniper Pharm Inc (JNP)

Juniper Pharm Inc (JNP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Juniper Pharm Inc 33 Arch Street Boston MA 02110 USA

www.juniperpharma.com P: 617-639-1500

Description:

Juniper Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company is focused on developing therapeutics for women's health. Juniper Pharmaceuticals, Inc., formerly known as COLUMBIA LABS, is based in Boston, United States.

Key Statistics

Overview:

Market Capitalization, $K 130,180
Shares Outstanding, K 11,320
Annual Sales, $ 49,980 K
Annual Net Income, $ -2,060 K
Last Quarter Sales, $ 15,310 K
Last Quarter Net Income, $ -1,510 K
60-Month Beta 0.66
% of Insider Shareholders 7.20%
% of Institutional Shareholders 45.56%

Growth:

1-Year Return 158.43%
3-Year Return 19.42%
5-Year Return 44.29%
5-Year Revenue Growth 93.50%
5-Year Earnings Growth -146.88%
5-Year Dividend Growth 0.00%

Per-Share Information:

Latest Earnings Date 08/09/18
Earnings Per Share ttm -0.05
EPS Growth vs. Prev Qtr -333.33%
EPS Growth vs. Prev Year -366.67%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-8 on 08/09/13

JNP Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward 76.67
Price/Earnings to Growth N/A
Return-on-Equity % -1.09%
Return-on-Assets % -0.77%
Profit Margin % -4.12%
Debt/Equity 0.08
Price/Sales 2.60
Price/Cash Flow 656.35
Price/Book 2.63
Book Value/Share 4.36
Interest Coverage -16.31
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar